Tetra Bio Pharma Inc (TBP.CA) Stock Income Statement
TSX:TBP - Toronto Stock Exchange - CA88166Y1007 - Common Stock - Currency: CAD
| TTM (2022-8-31) | 2021 (2021-11-30) | 2020 (2020-11-30) | 2019 (2019-11-30) | 2018 (2018-11-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 280.00K | |||
| Operating Expenses | 13.16M | 24.30M | 20.36M | 12.86M | 11.46M | |||
| Research and Development | 7.32M | 11.94M | 11.65M | 6.20M | 5.96M | |||
| Selling, General, and Administrative Expenses | 5.74M | 12.25M | 8.77M | 6.72M | 5.61M | |||
| Operating Income | -13.16M | -24.30M | -20.36M | -12.86M | -11.46M | |||
| Interest Income/Expense | -3.30M | -3.25M | -390.00K | -220.00K | -260.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | N/A | |||
| Non Recurring Items | N/A | -24.63M | -400.00K | 0.00 | 3.88M | |||
| Income Before Taxes | -39.02M | -52.18M | -21.15M | -13.08M | -7.84M | |||
| Net Income | -39.02M | -52.18M | -26.48M | -15.28M | -7.57M | |||
| EBITDA | -13.06M | -24.18M | -20.33M | -12.83M | -11.45M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.09 | -0.12 | -0.10 | -0.07 | -0.05 | |||
| Statistics | ||||||||
All data in CAD